FilingsTodayAlbemarle
At a glance
Albemarle reported 2025 revenue of $5.14B, down 4.4% from $5.38B in 2024. Over 4 years since 2021 ($3.33B), that is growth of about 11.5% a year. Operating margin was -7.1%, down from 24% in 2021. Revenue peaked in 2023 at $9.62B. The company posted a loss in 2024 and 2025.
In the last 12 months 3 insiders reported 0 open-market purchases and 4 sales ($7.4M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $3M by Chairman & CEO J Kent Masters on May 19, 2026.
Albemarle filed 15 current reports (Form 8-K) in the last 12 months, most often for officer or director change (8), results of operations (4), material agreement (2) and agreement terminated (1). The latest officer or director change was reported on Sep 3, 2026. It reported a material agreement or a completed acquisition or disposal 3 times.
2 of the 20 investors tracked here held Albemarle at the last quarter end, worth $77.3M combined. It is the largest weight for Renaissance Technologies (0.1% of its portfolio), followed by Bridgewater Associates (0.1%). Added: Bridgewater Associates. Reduced: Renaissance Technologies.
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $123.7M | $2.69B | $1.57B | -$1.18B | -$510.6M |
| Diluted EPS | $1.06 | $22.84 | $13.36 | $-11.20 | $-5.76 |
| Dividend per share | $1.56 | $1.58 | $1.60 | $1.61 | $1.62 |
Fiscal year ends Dec 31 · incorporated in VA
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined